News

14 Dec 2022 Ibex deploys AI-powered cancer diagnostics solution at UPMC

Read more

7 Dec 2022 Leading UK diagnostics provider source LDPath expands AI capabilities with Ibex Medical Analytics

Read more

4 Sep 2022 Ibex announces Galen™ 3.0, a transformative cancer diagnostics platform offering new detection capabilities and a broad feature set

Read more

2 Sep 2022 Ibex and Medipath sign multi-year, multi-site and multi-tissue expansion of AI for cancer diagnosis across France

Read more

1 Sep 2022 Excellent outcomes for Galen Breast

Read more

15 Jun 2022 Ibex obtains CE mark for Galen Gastric, the world’s first AI-powered solution for gastric cancer detection

Read more

21 Mar 2022 Hartford HealthCare and Ibex launch research initiative on AI-powered solution to improve breast cancer diagnosis

Read more

10 Mar 2022 Dedalus and Ibex announce a strategic partnership to bring the power of artificial intelligence to digital pathology

Read more

24 Nov 2021 Ibex selected by India’s Dr. Lal PathLabs to Deliver AI-powered Cancer Diagnostics

Read more

3 Nov 2021 Ibex selected by Kantonsspital Baselland to deliver the first AI-powered cancer diagnostics solution in Switzerland

Read more

18 Oct 2021 Roche announces collaboration with Ibex Medical Analytics to develop artificial intelligence-based digital pathology applications for improved patient care

Read more

14 Sep 2021 Ibex expands United States operations: appointing Douglas Clark MD, as Chief Medical Officer, Americas; CEO relocating to lead U.S. headquarters

Read more